You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 147 No. 8, August 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (55)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Efficacy and Safety of Nonsteroidal Anti-inflammatory Drugs in the Therapy of Diabetic Neuropathy

Kenneth L. Cohen, MD; Susanne Harris, PA-C

Arch Intern Med. 1987;147(8):1442-1444.


Abstract

• A study comparing ibuprofen (600 mg four times a day) vs sulindac (200 mg twice a day), and a placebo in the treatment of painful diabetic peripheral neuropathy was conducted in 18 male outpatients. Discomfort was characterized and rated with a subjective neuropathy score. The response to both ibuprofen and sulindac was better than it was to placebo in the entire group. There were no changes in glucose control or renal function. Further studies are necessary to evaluate the significance of aldose reductase—inhibitor properties of nonsteroidal anti-inflammatory drugs and to select the "best" one of these drugs for the treatment of diabetic neuropathy.

(Arch Intern Med 1987;147:1442-1444)



Author Affiliations

From the Department of Medicine, Yale University School of Medicine, New Haven, Conn, and the West Haven (Conn) Veterans Administration Medical Center.


Footnotes

Accepted for publication May 7, 1987.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy
Rutkove
JAMA 2009;302:1451-1458.
ABSTRACT | FULL TEXT  

Memantine (Namenda) for Neuropathic Pain
Rogers et al.
AM J HOSP PALLIAT CARE 2009;26:57-59.
ABSTRACT  

Further Investigation of the Negative Association between Hypertension and Peripheral Neuropathy in the Elderly: An Oklahoma Physicians Resource/Research Network (OKPRN) Study.
Cho et al.
J Am Board Fam Med 2006;19:240-250.
ABSTRACT | FULL TEXT  

Diabetic neuropathy
Bansal et al.
Postgrad. Med. J. 2006;82:95-100.
ABSTRACT | FULL TEXT  

Practical Management of Patients With Painful Diabetic Neuropathy
Corbett
The Diabetes Educator 2005;31:523-540.
ABSTRACT | FULL TEXT  

Elevated Spinal Cyclooxygenase and Prostaglandin Release During Hyperalgesia in Diabetic Rats
Freshwater et al.
Diabetes 2002;51:2249-2255.
ABSTRACT | FULL TEXT  

Drug treatment of neuropathic pain
DTB 2000;38:89-93.
ABSTRACT | FULL TEXT  

Intravenous Infusion of Phenytoin Relieves Neuropathic Pain: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Study
McCleane
Anesth. Analg. 1999;89:985-985.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.